Anglesio et al. [30] have reported that epithelium from deep-infiltrating endometriotic lesions carries known cancer driver mutations: KRAS, PPP2R1A, PIK3CA, and ARID1A from 5 of 24 patients (21%). This evidence concerns the gene ARID1A and cancer.